Report Detail

Pharma & Healthcare Global Newcastle Disease Vaccine Market Growth 2019-2024

  • RnM3050783
  • |
  • 05 March, 2019
  • |
  • Global
  • |
  • 158 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

According to this study, over the next five years the Newcastle Disease Vaccine market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 340 million by 2024, from US$ 280 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Newcastle Disease Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Newcastle Disease Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Live Vaccines
Killed Vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Chicken
Duck & Goose
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Newcastle Disease Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Newcastle Disease Vaccine market by identifying its various subsegments.
Focuses on the key global Newcastle Disease Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Newcastle Disease Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Newcastle Disease Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Newcastle Disease Vaccine Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Newcastle Disease Vaccine Consumption 2014-2024
        • 2.1.2 Newcastle Disease Vaccine Consumption CAGR by Region
      • 2.2 Newcastle Disease Vaccine Segment by Type
        • 2.2.1 Live Vaccines
        • 2.2.2 Killed Vaccines
      • 2.3 Newcastle Disease Vaccine Consumption by Type
        • 2.3.1 Global Newcastle Disease Vaccine Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Newcastle Disease Vaccine Sale Price by Type (2014-2019)
      • 2.4 Newcastle Disease Vaccine Segment by Application
        • 2.4.1 Chicken
        • 2.4.2 Duck & Goose
        • 2.4.3 Other
      • 2.5 Newcastle Disease Vaccine Consumption by Application
        • 2.5.1 Global Newcastle Disease Vaccine Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Newcastle Disease Vaccine Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Newcastle Disease Vaccine Sale Price by Application (2014-2019)

      3 Global Newcastle Disease Vaccine by Players

      • 3.1 Global Newcastle Disease Vaccine Sales Market Share by Players
        • 3.1.1 Global Newcastle Disease Vaccine Sales by Players (2017-2019)
        • 3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Players (2017-2019)
      • 3.2 Global Newcastle Disease Vaccine Revenue Market Share by Players
        • 3.2.1 Global Newcastle Disease Vaccine Revenue by Players (2017-2019)
        • 3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Players (2017-2019)
      • 3.3 Global Newcastle Disease Vaccine Sale Price by Players
      • 3.4 Global Newcastle Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Newcastle Disease Vaccine Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Newcastle Disease Vaccine Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Newcastle Disease Vaccine by Regions

      • 4.1 Newcastle Disease Vaccine by Regions
        • 4.1.1 Global Newcastle Disease Vaccine Consumption by Regions
        • 4.1.2 Global Newcastle Disease Vaccine Value by Regions
      • 4.2 Americas Newcastle Disease Vaccine Consumption Growth
      • 4.3 APAC Newcastle Disease Vaccine Consumption Growth
      • 4.4 Europe Newcastle Disease Vaccine Consumption Growth
      • 4.5 Middle East & Africa Newcastle Disease Vaccine Consumption Growth

      5 Americas

      • 5.1 Americas Newcastle Disease Vaccine Consumption by Countries
        • 5.1.1 Americas Newcastle Disease Vaccine Consumption by Countries (2014-2019)
        • 5.1.2 Americas Newcastle Disease Vaccine Value by Countries (2014-2019)
      • 5.2 Americas Newcastle Disease Vaccine Consumption by Type
      • 5.3 Americas Newcastle Disease Vaccine Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Newcastle Disease Vaccine Consumption by Countries
        • 6.1.1 APAC Newcastle Disease Vaccine Consumption by Countries (2014-2019)
        • 6.1.2 APAC Newcastle Disease Vaccine Value by Countries (2014-2019)
      • 6.2 APAC Newcastle Disease Vaccine Consumption by Type
      • 6.3 APAC Newcastle Disease Vaccine Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Newcastle Disease Vaccine by Countries
        • 7.1.1 Europe Newcastle Disease Vaccine Consumption by Countries (2014-2019)
        • 7.1.2 Europe Newcastle Disease Vaccine Value by Countries (2014-2019)
      • 7.2 Europe Newcastle Disease Vaccine Consumption by Type
      • 7.3 Europe Newcastle Disease Vaccine Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Newcastle Disease Vaccine by Countries
        • 8.1.1 Middle East & Africa Newcastle Disease Vaccine Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Newcastle Disease Vaccine Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Newcastle Disease Vaccine Consumption by Type
      • 8.3 Middle East & Africa Newcastle Disease Vaccine Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Newcastle Disease Vaccine Distributors
      • 10.3 Newcastle Disease Vaccine Customer

      11 Global Newcastle Disease Vaccine Market Forecast

      • 11.1 Global Newcastle Disease Vaccine Consumption Forecast (2019-2024)
      • 11.2 Global Newcastle Disease Vaccine Forecast by Regions
        • 11.2.1 Global Newcastle Disease Vaccine Forecast by Regions (2019-2024)
        • 11.2.2 Global Newcastle Disease Vaccine Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Newcastle Disease Vaccine Forecast by Type
      • 11.8 Global Newcastle Disease Vaccine Forecast by Application

      12 Key Players Analysis

      • 12.1 Merial
        • 12.1.1 Company Details
        • 12.1.2 Newcastle Disease Vaccine Product Offered
        • 12.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Merial News
      • 12.2 CEVA
        • 12.2.1 Company Details
        • 12.2.2 Newcastle Disease Vaccine Product Offered
        • 12.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 CEVA News
      • 12.3 QYH Biotech
        • 12.3.1 Company Details
        • 12.3.2 Newcastle Disease Vaccine Product Offered
        • 12.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 QYH Biotech News
      • 12.4 Ringpu Biology
        • 12.4.1 Company Details
        • 12.4.2 Newcastle Disease Vaccine Product Offered
        • 12.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Ringpu Biology News
      • 12.5 Yebio
        • 12.5.1 Company Details
        • 12.5.2 Newcastle Disease Vaccine Product Offered
        • 12.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Yebio News
      • 12.6 Harbin Veterinary Research Institute
        • 12.6.1 Company Details
        • 12.6.2 Newcastle Disease Vaccine Product Offered
        • 12.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Harbin Veterinary Research Institute News
      • 12.7 Merck Animal Health
        • 12.7.1 Company Details
        • 12.7.2 Newcastle Disease Vaccine Product Offered
        • 12.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Merck Animal Health News
      • 12.8 DHN
        • 12.8.1 Company Details
        • 12.8.2 Newcastle Disease Vaccine Product Offered
        • 12.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 DHN News
      • 12.9 Zoetis
        • 12.9.1 Company Details
        • 12.9.2 Newcastle Disease Vaccine Product Offered
        • 12.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Zoetis News
      • 12.10 ChengDu Tecbond
        • 12.10.1 Company Details
        • 12.10.2 Newcastle Disease Vaccine Product Offered
        • 12.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 ChengDu Tecbond News
      • 12.11 Elanco (Lohmann)
      • 12.12 FATRO
      • 12.13 CAVAC
      • 12.14 Vaksindo

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Newcastle Disease Vaccine . Industry analysis & Market Report on Newcastle Disease Vaccine is a syndicated market report, published as Global Newcastle Disease Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Newcastle Disease Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,895.06
      4,342.59
      5,790.12
      3,374.52
      5,061.78
      6,749.04
      568,398.00
      852,597.00
      1,136,796.00
      305,610.00
      458,415.00
      611,220.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report